These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
530 related articles for article (PubMed ID: 16421364)
1. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. Elkins MR; Robinson M; Rose BR; Harbour C; Moriarty CP; Marks GB; Belousova EG; Xuan W; Bye PT; N Engl J Med; 2006 Jan; 354(3):229-40. PubMed ID: 16421364 [TBL] [Abstract][Full Text] [Related]
2. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. Donaldson SH; Bennett WD; Zeman KL; Knowles MR; Tarran R; Boucher RC N Engl J Med; 2006 Jan; 354(3):241-50. PubMed ID: 16421365 [TBL] [Abstract][Full Text] [Related]
3. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. Rosenfeld M; Ratjen F; Brumback L; Daniel S; Rowbotham R; McNamara S; Johnson R; Kronmal R; Davis SD; JAMA; 2012 Jun; 307(21):2269-77. PubMed ID: 22610452 [TBL] [Abstract][Full Text] [Related]
4. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial. Ratjen F; Davis SD; Stanojevic S; Kronmal RA; Hinckley Stukovsky KD; Jorgensen N; Rosenfeld M; Lancet Respir Med; 2019 Sep; 7(9):802-809. PubMed ID: 31178421 [TBL] [Abstract][Full Text] [Related]
5. The effects of albuterol on the lung function of hospitalized patients with cystic fibrosis. Hordvik NL; Sammut PH; Judy CG; Strizek SJ; Colombo JL Am J Respir Crit Care Med; 1996 Jul; 154(1):156-60. PubMed ID: 8680672 [TBL] [Abstract][Full Text] [Related]
6. Effects of inhaled hypertonic (7%) saline on lung function test in preschool children with cystic fibrosis: results of a crossover, randomized clinical trial. Nenna R; Midulla F; Lambiase C; De Castro G; Zicari AM; Indinnimeo L; Cimino G; Troiani P; Quattrucci S; Tancredi G Ital J Pediatr; 2017 Jul; 43(1):60. PubMed ID: 28709466 [TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid improves the tolerability of hypertonic saline in the chronic treatment of cystic fibrosis patients: a multicenter, randomized, controlled clinical trial. Ros M; Casciaro R; Lucca F; Troiani P; Salonini E; Favilli F; Quattrucci S; Sher D; Assael BM J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):133-7. PubMed ID: 23745525 [TBL] [Abstract][Full Text] [Related]
8. Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis. Brivio A; Conese M; Gambazza S; Biffi A; Tirelli AS; Russo M; Foà M; Colombo C J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):482-489. PubMed ID: 27149365 [TBL] [Abstract][Full Text] [Related]
9. Nebulised hypertonic saline for cystic fibrosis. Wark PA; McDonald V; Jones AP Cochrane Database Syst Rev; 2005 Jul; (3):CD001506. PubMed ID: 16034863 [TBL] [Abstract][Full Text] [Related]
10. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Robinson M; Hemming AL; Regnis JA; Wong AG; Bailey DL; Bautovich GJ; King M; Bye PT Thorax; 1997 Oct; 52(10):900-3. PubMed ID: 9404379 [TBL] [Abstract][Full Text] [Related]
14. Comparison of effects of 3 and 7% hypertonic saline nebulization on lung function in children with cystic fibrosis: a double-blind randomized, controlled trial. Gupta S; Ahmed F; Lodha R; Gupta YK; Kabra SK J Trop Pediatr; 2012 Oct; 58(5):375-81. PubMed ID: 22374985 [TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial to evaluate the lung clearance index as an outcome measure for early phase studies in patients with cystic fibrosis. Amin R; Stanojevic S; Kane M; Webster H; Ratjen F Respir Med; 2016 Mar; 112():59-64. PubMed ID: 26856191 [TBL] [Abstract][Full Text] [Related]
16. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210 [TBL] [Abstract][Full Text] [Related]
17. A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis. Dentice RL; Elkins MR; Middleton PG; Bishop JR; Wark PA; Dorahy DJ; Harmer CJ; Hu H; Bye PT Thorax; 2016 Feb; 71(2):141-7. PubMed ID: 26769016 [TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis. Dellon EP; Donaldson SH; Johnson R; Davis SD Pediatr Pulmonol; 2008 Nov; 43(11):1100-1106. PubMed ID: 18828160 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis. Hordvik NL; Sammut PH; Judy CG; Colombo JL Pediatr Pulmonol; 2002 Oct; 34(4):287-96. PubMed ID: 12205570 [TBL] [Abstract][Full Text] [Related]